Who
Weber Lara Smith
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Fractyl Health.
In numbers
- Trades disclosed
- 4
- Buys
- 1
- Sells
- 0
- Bought
- $28K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Jan 2026
- Last trade
- 8 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jun 2026filed 9 Jun 2026 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $14K20,000 at $0.6854 | filing |
| 8 Jun 2026filed 9 Jun 2026 | GUTS Fractyl HealthMedical Devices | SEC FORM 4 Bought | $14K20,000 at $0.69 | filing |
| 12 Jan 2026filed 14 Jan 2026 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,036,800 at $0.00 | filing |
| 12 Jan 2026filed 14 Jan 2026 | GUTS Fractyl Healthoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,036,800 at $0.00 | filing |
News
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight MaintenanceGUTS · manilatimes.net · 22 Oct 2026Fractyl Health Stock Plunges 48% Despite Positive Revita Weight-Maintenance Trial ResultsGUTS · rttnews.com · 16 Oct 2026Analyzing Zealand Pharma A/S (OTCMKTS:ZLDPF) & Fractyl Health (NASDAQ:GUTS)GUTS · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name Weber Lara Smith; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.